Market Tracker

01/30 6:05pm ET

Amgen Inc (NASDAQ:AMGN)

152.26
Data as of Jan 30
 -4.11 / -2.63%
Today’s Change
108.20
Today|||52-Week Range
173.14
-4.41%
Year-to-Date

Today’s Trading

Previous close156.37
Today’s open155.55
Day’s range151.53 - 156.87
Volume5,318,204
Average volume (3 months)3,497,269
Market cap$118.8B
Dividend yield2.08%
Data as of 3:59pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)+20.29%
Earnings growth (this year)+13.08%
Earnings growth (next 5 years)+10.05%
Revenue growth (last year)+8.61%
P/E ratio24.0
Price/Sales4.60
Price/Book5.34

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+35.91+10.17%
GILDGilead Sciences+0.65+0.62%
BAXBaxter International...-1.07-1.50%
GEVASynageva BioPharma C...-5.23-4.34%
Data as of 4:14pm ET, 01/30/2015

Financials

Last reporting dateJanuary 27, 2015
EPS forecast (this quarter)$2.05
Annual revenue (last year)$18.7B
Annual profit (last year)$5.1B
Net profit margin27.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts